Quinidine
It is an alkaloid from Cinchona bark-the dextroisomer of quinine & has been noted to suppress ‘rebellious palpitation.’ Quinidine increases threshold for excitation and reduces conduction velocity, thus limits the spread of arrhythmia.Atrial fibrillation or flutter, paroxysmal supra ventricular tachycardia. Ventricular premature beats & ventricular tachycardia. Maintenance of sinus rhythm following electro conversion.
200-300 mg 3-4 times daily. Initially give test dose.
Not recommended for children. Myasthenia gravis. Intolerance or idiosyncrasy to quinidine, heart block, C.H.F. and hypotensive states. History of embolism.
Renal dysfunctions. Paediatric: Not recommended. Pregnancy: No serious effect reported. Lactation: Not recommended. Elderly: Reduced dosage necessary.
Higher doses can cause A.V. dissociation, nausea, vomiting, diarrhoea, cinchonism (ringing in ear, deafness, vertigo, headache, visual disturbances), angioedema, asthma & vascular collapse.
Cimetidine, erythromycin inhibits the hepatic metabolism of quinidine, interaction with beta-blockers causes sinus bradycardia. Amiodarone may increase the plasma concentration of quinidine. Phenobarbitone and rifampicin decreases its effects. Hyperkalemia increases effect of quinidine.
Brand Name | Manufactured by |
---|---|
Natcardine | FRANCO INDIAN PHARMACEUTICAL LTD. |
Qrite | USV LTD. |